Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

4 ArticlesGLENMARK

1 / 1

Glenmark Life Sciences IPO – Should you invest?

The rush to IPO continues. This time for a subsidiary of a Pharma major - Glenmark Pharma. The company had spun off its API business in 2019 & understandably ...
Glenmark-Life.jpg

FDA’s New Rules Propels Generic and Biosimilar Approvals

Effective January 9th 2017, the US Food and Drug Administration (FDA) has announced an amendment to the final rule ((the rule governs the manner in which FDA ...
Original-Abbreviated-New-Drug-Application-ANDA-Approvals-10-November-2016.png

Aurobindo, Glenmark and Sun Pharma receive ANDA approval for Rosuvastatin Calcium Tablets

This does not happen everyday but today, the US FDA happened to approve the ANDA filings of 3 pharmacos (Aurobindo Pharma, Glenmark Pharmaceutical and Sun ...
Auro-Sun-Glenmark-Share-Price.png

Exclusive: Glenmark Pharmaceuticals form 483 for Pithampur facility

At Capital Mind, we bring you today another exclusive article in lines with our earlier production of the exclusive series on Lupin Pharmaceuticals form 483 ...